JCR Pharmaceuticals
A global specialty pharmaceuticals company developing treatments for rare and genetic diseases.
The Japanese company's investigational products are aimed at treating rare diseases including MPS I (Hurler, HurlerScheie and Scheie syndrome), MPS II (Hunter syndrome), MPS III A and B (Sanfilippo syndrome type A and B), and more.
Latest JCR Pharmaceuticals News & Features
2 January 2024
21 December 2023
Today's issue
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze